Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(4):519–533. doi: 10.1111/j.1750-3639.2003.tb00482.x

A 40‐cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis

Shunya Nakane 1, Laurie J Zoecklein 1, Jeffrey D Gamez 1, Louisa M Papke 1, Kevin D Pavelko 1, Jean‐François Bureau 3, Michel Brahic 3, Larry R Pease 2, Moses Rodriguez 1,2,✉
PMCID: PMC8095950  PMID: 14655757

Abstract

Theiler's virus persists and induces immunemediated demyelination in susceptible mice and serves as a model of multiple sclerosis. Previously, we identified 4 markers–D14Mit54, D14Mit60, D14Mit61, and D14Mit90–in a 40‐cM region of chromosome 14 that are associated with demyelination in a cross between susceptible DBA/2 and resistant B10.D2 mice. We generated congenic‐inbred mice to examine the contribution of this 40‐cM region to disease. DBA Chr.14B10 mice, containing the chromosomal segment marked by the microsatellite polymorphisms, developed less spinal cord demyelination than did DBA/2 mice. More demyelination was found in the reciprocal congenic mouse B10.D2 Chr.14D2 than in the B10.D2 strain. Introduction of the DBA/2 chromosomal region onto the B10.D2 genetic background resulted in more severe disease in the striatum and cortex relative to B10.D2 mice. The importance of the marked region of chromosome 14 is indicated by the decrease in neurological performance using the Rotarod test during chronic disease in B10.D2 Chr.14D2 mice in comparison to B10.D2 mice. Viral replication was increased in B10.D2 Chr.14D2 mice as determined by quantitative real‐time RT‐PCR. These results indicate that the 40‐cM region on chromosome 14 of DBA/2 mice contributes to viral persistence, subsequent demyelination, and loss of neurological function.

Full Text

The Full Text of this article is available as a PDF (803.9 KB).

References

  • 1. Abbadi N, Nadeau JH (1998) Encyclopedia of the mouse genome VII. Mouse chromosome 14. Mamm Genome 8:S275–291. [DOI] [PubMed] [Google Scholar]
  • 2. Aubagnac S, Brahic M, Bureau JF (1999) Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J Virol 73:7965–7791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Aubagnac S, Brahic M, Bureau JF (2001) Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the β2m gene. J Virol 75:7723–7726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Azoulay‐Cayla A, Syan S, Brahic M, Bureau JF (2001) Roles of the H‐2D b and H‐Kb genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J Gen Virol 82:1043–1047. [DOI] [PubMed] [Google Scholar]
  • 5. Battistini L, Selmaj K, Kowal C, Ohmen J, Modlin RL, Raine CS, Brosnan CF (1995) Multiple sclerosis: limited diversity of the Vδ 2‐Jδ 3 T‐cell receptor in chronic active lesions. Ann Neurol 37:198–203. [DOI] [PubMed] [Google Scholar]
  • 6. Bever CT Jr, Panitch HS, Johnson KP (1994) Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients. Neurology 44:745–748. [DOI] [PubMed] [Google Scholar]
  • 7. Bever CT Jr, Garver DW (1995) Increased cathepsin B activity in multiple sclerosis brain. J Neurol Sci 131:71–73. [DOI] [PubMed] [Google Scholar]
  • 8. Bihl F, Pena‐Rossi C, Guenet JL, Brahic M, Bureau JF (1997) The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J Virol 71:5025–5030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Bihl F, Brahic M, Bureau JF (1999) Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics 52:385–392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271–278. [DOI] [PubMed] [Google Scholar]
  • 11. Blankenhorn EP, Stranford SA (1992) Genetic factors in demyelinating diseases: genes that control demyelination due to experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalitis virus. Reg Immunol 4:331–343. [PubMed] [Google Scholar]
  • 12. Bluyssen AR, Durbin JE, Levy DE (1996) ISGF3γ p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev 7:11–17. [DOI] [PubMed] [Google Scholar]
  • 13. Brahic M, Bureau JF (1998) Genetics of susceptibility to Theiler's virus infection. Bioessays 20:627–633. [DOI] [PubMed] [Google Scholar]
  • 14. Brosnan CF, Raine CS (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243–257. [DOI] [PubMed] [Google Scholar]
  • 15. Bureau JF, Montagutelli X, Lefebvre S, Guenet JL, Pla M, Brahic M (1992) The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J Virol 66:4698–4704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Bureau JF, Montagutelli X, Bihl F, Lefebvre S, Guenet JL, Brahic M (1993) Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet 5:87–91. [DOI] [PubMed] [Google Scholar]
  • 17. Bureau JF, Drescher KM, Pease LR, Vikoren T, Delcroix M, Zoecklein L, Brahic M, Rodriguez M (1998) Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus‐induced demyelination in the mouse. Genetics 148:1941–1949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985) Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease in mice is influenced by the H‐2D region: correlation with TEMV‐specific delayed‐type hypersensitivity. J Immunol 135:1408–1414. [PubMed] [Google Scholar]
  • 19. Dal Canto MC, Lipton HL (1977) Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am J Pathol 88:497–500. [PMC free article] [PubMed] [Google Scholar]
  • 20. Dal Canto MC, Lipton H L (1977) Anew model of persistent viral infection with primary demyelination. Neurol Neurocir Psiquiatr 18(2–3 Suppl):455–467. [PubMed] [Google Scholar]
  • 21. DerSimonian H, Sugita M, Glass DN, Maier AL, Weinblatt ME, Reme T, Brenner MB (1993) Clonal V _12.1 + T‐cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 177:1623–1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Dethlefs S, Escriou N, Brahic M, van der Werf S, Larsson‐Sciard EL (1997) Theiler's virus and Mengo virus induce cross‐reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol 71:5361–5365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Drescher KM, Johnston SL, Hogancamp W, Nabozny GH, David CS, Rimm IJ, Wettstein PJ, Rodriguez M (2000) Vβ8+ T‐cells protect from demyelinating disease in a viral model of multiple sclerosis. Int Immunol 12:271–280. [DOI] [PubMed] [Google Scholar]
  • 24. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O'Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, Pryse‐Phillips W, Nelson R, Freedman M, Brunet D, Bouchard JP, Hinds D, Risch N (1996) A full genome search in multiple sclerosis. Nat Genet 13:472–476. [DOI] [PubMed] [Google Scholar]
  • 25. Gibson L, Holmgreen SP, Huang DC, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM, Cory S (1996) bcl‐w, a novel member of the bcl‐2 family, promotes cell survival. Oncogene 13:665–675. [PubMed] [Google Scholar]
  • 26. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17:595–606. [DOI] [PubMed] [Google Scholar]
  • 27. Hafler DA, Saadeh MG, Kuchroo VK, Milford E, Steinman L (1996) TCR usage in human and experimental demyelinating disease. Immunol Today 17:152–159. [DOI] [PubMed] [Google Scholar]
  • 28. Haines JL, Ter‐Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak‐Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Garcia‐Merino A, Gatto N, Young S, Oksenberg JR (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469–471. [DOI] [PubMed] [Google Scholar]
  • 29. Heber‐Katz E, Acha‐Orbea H (1989) The V‐region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today 10:164–169. [DOI] [PubMed] [Google Scholar]
  • 30. Heusel JW, Scarpati EM, Jenkins NA, Gilbert DJ, Copeland NG, Shapiro SD, Ley TJ (1993) Molecular cloning, chromosomal location, and tissue‐specific expression of the murine cathepsin G gene. Blood 81:1614–1623. [PubMed] [Google Scholar]
  • 31. Hillert J, Leng C, Olerup O (1992) T‐cell receptor a chain germline gene polymorphisms in multiple sclerosis. Neurology 42:80–84. [DOI] [PubMed] [Google Scholar]
  • 32. Hohlfeld R (1997) Biotechnical agents for the immunotherapy of multiple sclerosis: principles, problems and perspectives. Brain 120:865–916. [DOI] [PubMed] [Google Scholar]
  • 33. Hong NA, Kabra NH, Hsieh SN, Cado D, Winoto A (1999) In vivo overexpression of Dad1, the defender against apoptotic death‐1, enhances T‐cell proliferation but does not protect against apoptosis. J Immunol 163:1888–1893. [PubMed] [Google Scholar]
  • 34. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR (1999) Prevalent class I‐restricted T‐cell response to the Theiler's virus epitope Db: VP2121–130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73:3702–3708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR (2001) Preservation of motor function by inhibition of CD8+ virus peptide‐specific T‐cells in Theiler's virus infection. FASEB J 15:2760–2762. [DOI] [PubMed] [Google Scholar]
  • 36. Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstroem E, Stefferl A, Zimprich F, Olsson T, Linington C, Schmidbauer M, Lassmann H (2001) Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 124:1114–1124. [DOI] [PubMed] [Google Scholar]
  • 37. Lipton HL, Melvold R, Miller SD, Dal Canto MC (1995) Mutation of a major histocompatibility class I locus, H‐2D, leads to an increased virus burden and disease susceptibility in Theiler's virus‐induced demyelinating disease. J Neurovirol 1:138–144. [DOI] [PubMed] [Google Scholar]
  • 38. Lucchinetti C, Bruck W, Noseworthy J (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 14:259–269. [DOI] [PubMed] [Google Scholar]
  • 39. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA (1997) Bone morphogenetic proteins induce astroglial differentiation of oligodendroglialastroglial progenitor cells. J Neurosci 17:4112–4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Mabie PC, Mehler MF, Kessler JA (1999) Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19:7077–7088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. McGavern DB, Zoecklein L, Drescher KM, Rodriguez M (1999) Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 158:171–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. McGavern DB, Murray PD, Rivera‐Quinones C, Schmelzer JD, Low PA, Rodriguez M (2000) Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 123:519–531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Mehler MF, Mabie PC, Zhu G, Gokhan S, Kessler JA (2000) Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev Neurosci 22:74–85. [DOI] [PubMed] [Google Scholar]
  • 44. Melvold RW, Jokinen DM, Knobler RL, Lipton HL (1987) Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T‐cell β‐chain constant gene on chromosome 6. J Immunol 138:1429–1433. [PubMed] [Google Scholar]
  • 45. Monteyne P, Bureau JF, Brahic M (1997) The infection of mouse by Theiler's virus: from genetics to immunology. Immunol Rev 159:163–176. [DOI] [PubMed] [Google Scholar]
  • 46. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998) Perforin‐dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18:7306–7314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 243:938–950. [DOI] [PubMed] [Google Scholar]
  • 48. Offner H, Vandenbark AA (1999) T‐cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP‐specific clones. Int Rev Immunol 18:9–36. [DOI] [PubMed] [Google Scholar]
  • 49. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, Bernard CC (1990) Limited heterogeneity of rearranged T‐cell receptor V αtranscripts in brains of multiple sclerosis patients. Nature 24:344–346. [DOI] [PubMed] [Google Scholar]
  • 50. Owens T, Sriram S (1995) The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin 1995; 13:51–73. [PubMed] [Google Scholar]
  • 51. Pierce M, Rodriguez M (1989) Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J Histotechnol 12:35–36. [Google Scholar]
  • 52. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis. Ann Neurol 13:426–433. [DOI] [PubMed] [Google Scholar]
  • 53. Rodriguez M, Leibowitz JL, Powell HC, Lampert PW (1983) Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest 49:672–679. [PubMed] [Google Scholar]
  • 54. Rodriguez M, David CS (1985) Demyelination induced by Theiler's virus: influence of the H‐2 haplotype. J Immunol 135:2145–2148. [PubMed] [Google Scholar]
  • 55. Rodriguez M, Leibowitz J, David CS (1986) Susceptibility to Theiler's virus‐induced demyelination. Mapping of the gene within the H‐2D region. J Exp Med 163:620–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Rodriguez M, Patick AK, Pease LR, David CS (1992) Role of T‐cell receptor V4bT genes in Theiler's virus‐induced demyelination of mice. J Immunol 148:921–927. [PubMed] [Google Scholar]
  • 57. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R (1993) Abrogation of resistance to Theiler's virus‐induced demyelination in H‐2b mice deficient in β2‐microglobulin. J Immunol 151:266–276. [PubMed] [Google Scholar]
  • 58. Rodriguez M, Nabozny GH, Thiemann RL, David CS (1994) Influence of deletion of T‐cell receptor Vβ genes on the Theiler's virus model of multiple sclerosis. Autoimmunity 19:221–230. [DOI] [PubMed] [Google Scholar]
  • 59. Rodriguez M, David CS (1995) H‐2 Dd transgene suppresses Theiler's virus‐induced demyelination in susceptible strains of mice. J Neurovirol 1:111–117. [DOI] [PubMed] [Google Scholar]
  • 60. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet1 3:464–468. [DOI] [PubMed] [Google Scholar]
  • 61. Semra YK, Seidi OA, Sharief MK. (2002) Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122:132–139. [DOI] [PubMed] [Google Scholar]
  • 62. Silber E, Semra YK, Gregson NA, Sharief MK (2002) Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58:1372–1381. [DOI] [PubMed] [Google Scholar]
  • 63. Teuscher C, Rhein DM, Livingstone KD, Paynter RA, Doerge RW, Nicholson SM, Melvold RW (1997) Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice. J Immunol 159:4930–4934. [PubMed] [Google Scholar]
  • 64. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735–747. [DOI] [PubMed] [Google Scholar]
  • 65. Ure DR, Rodriguez M (2002) Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience 111:399–411. [DOI] [PubMed] [Google Scholar]
  • 66. Vandenbark AA, Morgan E, Bartholomew R, Bourdette D, Whitham R, Carlo D, Gold D, Hashim G, Offner H (2001) TCR peptide therapy in human autoimmune diseases. Neurochem Res 26:713–730. [DOI] [PubMed] [Google Scholar]
  • 67. Vaughan KT, Mikami A, Paschal BM, Holzbaur EL, Hughes SM, Echeverri CJ, Moore KJ, Gilbert DJ, Copeland NG, Jenkins NA, Vallee RB (1996) Multiple mouse chromosomal loci for dynein‐based motility. Genomics 36:29–38. [DOI] [PubMed] [Google Scholar]
  • 68. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998) Major histocompatibility complex class II alleles and the course and outcome of MS: a population‐based study. Neurology 51:742–747. [DOI] [PubMed] [Google Scholar]
  • 69. Zeine R, Pon R, Ladiwala U, Antel JP, Filion LG, Freedman MS (1998) Mechanism of yδ T‐cell‐induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J Neuroimmunol 87:49–61. [DOI] [PubMed] [Google Scholar]
  • 70. Zeine R, Cammer W, Barbarese E, Liu CC, Raine CS (2001) Structural dynamics of oligodendrocyte lysis by perforin in culture: relevance to multiple sclerosis. J Neurosci Res 64:380–391. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES